Prion protein — mediator of toxicity in multiple proteinopathies (original) (raw)

NEURODEGENERATIVE DISEASE

Nature Reviews Neurology volume 16, pages 187–188 (2020)Cite this article

Subjects

A new study shows that interactions of the cellular prion protein with amyloid-β, tau and α-synuclein oligomers are important in mediating the toxicity of these proteins in Alzheimer disease and Parkinson disease. The findings suggest a shared pathway that could be a therapeutic target common to multiple neurodegenerative diseases.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

$29.99 / 30 days

cancel any time

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

References

  1. Prusiner, S. B. A unifying role for prions in neurodegenerative diseases. Science 336, 1511–1513 (2012).
    Article CAS Google Scholar
  2. Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat. Rev. Mol. Cell. Biol. 8, 101–112 (2007).
    Article CAS Google Scholar
  3. Corbett, G. T. et al. PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins. Acta Neuropathol. 139, 503–526 (2019).
    Article Google Scholar
  4. Bessen, R. A. & Marsh, R. F. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68, 7859–7868 (1994).
    Article CAS Google Scholar
  5. Smith, L. M., Kostylev, M. A., Lee, S. & Strittmatter, S. M. Systematic and standardized comparison of reported amyloid-beta receptors for sufficiency, affinity, and Alzheimer’s disease relevance. J. Biol. Chem. 294, 6042–6053 (2019).
    Article CAS Google Scholar
  6. Guerrero-Ferreira, R. et al. Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy. eLife 8, e48907 (2019).
    Article Google Scholar
  7. Zhang, W. et al. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases. eLife 8, e43584 (2019).
    Article Google Scholar
  8. Um, J. W. et al. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer Aβ oligomer bound to cellular prion protein. Neuron 79, 887–902 (2013).
    Article CAS Google Scholar
  9. Friberg, K. N. et al. Intracerebral infusion of antisense oligonucleotides into prion-infected mice. Mol. Ther. Nucleic Acids 1, e9 (2012).
    Article Google Scholar
  10. Raymond, G. J. et al. Antisense oligonucleotides extend survival of prion-infected mice. JCI Insight 5, 131175 (2019).
    Article Google Scholar

Download references

Acknowledgements

The authors thank Nick A. Paras for useful discussions.

Author information

Authors and Affiliations

  1. Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA
    Jacob I. Ayers & Stanley B. Prusiner
  2. Department of Neurology, University of California, San Francisco, CA, USA
    Jacob I. Ayers & Stanley B. Prusiner
  3. Department of Biochemistry and Biophysics, University of California, San Francisco, CA, USA
    Stanley B. Prusiner

Authors

  1. Jacob I. Ayers
    You can also search for this author inPubMed Google Scholar
  2. Stanley B. Prusiner
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toStanley B. Prusiner.

Ethics declarations

Competing interests

The Institute for Neurodegenerative Diseases has a research collaboration with Daiichi Sankyo (Tokyo, Japan). S.B.P. is a member of the Scientific Advisory Board of ViewPoint Therapeutics and a member of the Board of Directors of Trizell. J.I.A. declares no competing interests.

Rights and permissions

About this article

Cite this article

Ayers, J.I., Prusiner, S.B. Prion protein — mediator of toxicity in multiple proteinopathies.Nat Rev Neurol 16, 187–188 (2020). https://doi.org/10.1038/s41582-020-0332-8

Download citation

This article is cited by